Calcium and calcium antagonists in the treatment of hypertension

Norman M Kaplan

Research output: Contribution to journalArticle

Abstract

Calcium antagonists will be increasingly used for the treatment of hypertension, largely because of their many attractive features including a mild natriuresis, effectiveness in elderly and black patients, and lack of metabolic side effects. In addition, they may improve one of the basic defects responsible for hypertension, an increase in intracellular calcium concentration. Calcium supplements have been advocated for the treatment of hypertension, but neither the rationale for their use nor their antihypertensive effectiveness has been documented. However, they may be rational and effective in a subgroup of the hypertensive population who have mild secondary hyperparathyroidism caused by renal hypercalciuria.

Original languageEnglish (US)
Pages (from-to)62-65
Number of pages4
JournalISI Atlas of Science: Pharmacology
Volume2
Issue number1
StatePublished - 1988

Fingerprint

Hypertension
Calcium
Hypercalciuria
Natriuresis
Secondary Hyperparathyroidism
Antihypertensive Agents
Therapeutics
Kidney
Population

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Calcium and calcium antagonists in the treatment of hypertension. / Kaplan, Norman M.

In: ISI Atlas of Science: Pharmacology, Vol. 2, No. 1, 1988, p. 62-65.

Research output: Contribution to journalArticle

@article{ef6535e646284085b72f536b0bc3b5e1,
title = "Calcium and calcium antagonists in the treatment of hypertension",
abstract = "Calcium antagonists will be increasingly used for the treatment of hypertension, largely because of their many attractive features including a mild natriuresis, effectiveness in elderly and black patients, and lack of metabolic side effects. In addition, they may improve one of the basic defects responsible for hypertension, an increase in intracellular calcium concentration. Calcium supplements have been advocated for the treatment of hypertension, but neither the rationale for their use nor their antihypertensive effectiveness has been documented. However, they may be rational and effective in a subgroup of the hypertensive population who have mild secondary hyperparathyroidism caused by renal hypercalciuria.",
author = "Kaplan, {Norman M}",
year = "1988",
language = "English (US)",
volume = "2",
pages = "62--65",
journal = "ISI Atlas of Science: Pharmacology",
issn = "0890-9083",
number = "1",

}

TY - JOUR

T1 - Calcium and calcium antagonists in the treatment of hypertension

AU - Kaplan, Norman M

PY - 1988

Y1 - 1988

N2 - Calcium antagonists will be increasingly used for the treatment of hypertension, largely because of their many attractive features including a mild natriuresis, effectiveness in elderly and black patients, and lack of metabolic side effects. In addition, they may improve one of the basic defects responsible for hypertension, an increase in intracellular calcium concentration. Calcium supplements have been advocated for the treatment of hypertension, but neither the rationale for their use nor their antihypertensive effectiveness has been documented. However, they may be rational and effective in a subgroup of the hypertensive population who have mild secondary hyperparathyroidism caused by renal hypercalciuria.

AB - Calcium antagonists will be increasingly used for the treatment of hypertension, largely because of their many attractive features including a mild natriuresis, effectiveness in elderly and black patients, and lack of metabolic side effects. In addition, they may improve one of the basic defects responsible for hypertension, an increase in intracellular calcium concentration. Calcium supplements have been advocated for the treatment of hypertension, but neither the rationale for their use nor their antihypertensive effectiveness has been documented. However, they may be rational and effective in a subgroup of the hypertensive population who have mild secondary hyperparathyroidism caused by renal hypercalciuria.

UR - http://www.scopus.com/inward/record.url?scp=0023899116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023899116&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0023899116

VL - 2

SP - 62

EP - 65

JO - ISI Atlas of Science: Pharmacology

JF - ISI Atlas of Science: Pharmacology

SN - 0890-9083

IS - 1

ER -